Approvals/TGA/OLAMLO HCT 40/10/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/10/12.5 mg film-coated tablet blister pack

Approved

STANDARD

OLAMLO HCT 40/10/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/10/12.5 mg film-coated tablet blister pack

Accord Healthcare Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 7f0bfb139ee2e0e1
Product Name: OLAMLO HCT 40/10/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/10/12.5 mg film-coated tablet blister pack
Artg Id: 312009
Artg Name: OLAMLO HCT 40/10/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/10/12.5 mg film-coated tablet blister pack
Sponsor: Accord Healthcare Pty Ltd
Company Detail Path: /organization/accord-healthcare-pty-ltd
Artg Date: 2019-11-21
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-01094-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-PI-02426-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

7f0bfb139ee2e0e1

Type

Standard